Clinical Trial

Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics

Study acronym: PROSPECT
Recruiting
View on ClinicalTrials.gov →
Summary
The etiology and specific pathogenesis of many cardiovascular diseases such as coronary atherosclerosis, cardiomyopathy, atrial fibrillation, and stroke are still unclear. Improving diagnosis and treatment, clarifying the pathogenesis, and providing scientific basis for the prevention and treatment are hot research topics in the study of cardiovascular and cerebrovascular diseases. This study intends to collect clinical data and biological specimen data of patients with cardiovascular and cerebrovascular diseases who meet the inclusion and exclusion criteria, and use multi-omics technology to deeply understand the pathogenic mechanisms of cardiovascular and cerebrovascular diseases and provide new ideas for specific and individualized treatment of patients with cardiovascular and cerebrovascular diseases, to construct early predictive prognostic models and provide a basis for effective treatment of clinical practice in patients with cardiovascular and cerebrovascular diseases.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-08-14; most recent amendment 2024-07-10.
Status change: Not Yet Recruiting → Recruiting 2024-07-10
Trial Details
NCT Number NCT06001073
Lead Sponsor First Affiliated Hospital Xi'an Jiaotong University
Collaborators: Xi'an Gaoxin Hospital, First Affiliated Hospital of Chongqing Medical University, General Hospital of Ningxia Medical University, Second Affiliated Hospital of Nanchang University
Conditions Coronary Artery Disease, Arrhythmias, Cardiac, Heart Valve Diseases, Aortic Dissection, Heart Neoplasms, Myocarditis, Hypertension, Cardiomyopathies +4 more
Enrollment 25,000 participants
Start Date 2022-12-05
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-12